Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRF and Corticosteroid Treatments in Impacted Third Molar Surgery
NCT07742826Recruiting
- Sponsor
- Final International University
- Start
- Sep 2024
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Randomised trial of platelet rich fibrin and dexamethasone in Impacted Mandibular Third Molar (IM3M) (3 arms), sponsored by Final International University. Primary endpoints: Postoperative Pain at 7 days, Postoperative Facial Swelling at 7 days and 1 more. Started Sep 2024; status: recruiting.
02
Drugs
platelet rich fibrindexamethasone
03
Conditions
Impacted Mandibular Third Molar (IM3M)
Beyond the preview
Go deeper on NCT07742826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07742826.